References
1. Ministry of Health of the Russian Federation. Statistical information for 2017 [Electronic resource]. URL: https://minzdrav.gov.ru/ministry/61/22/stranitsa-979/statisticheskie-i-informatsionnye-materi-aly/statisticheskiy-sbornik-2017-god (in Russian)
2. National program «Bronchial asthma in children. Treatment strategy and prevention». 5th ed. Moscow, 2017. (in Russian)
3. Galitskaya M.A., Kurbacheva O.M., Shilovsky I.P., Nikol’sky A.A., Nikonova A.A., Dyneva M.E., Khaitov M.R. Some features of inflammation in patients with atopic bronchial asthma when exposed to respiratory viruses. Immunologiya. 2020; 41 (2): 154-63. DOI: https://doi.org/10.33029/0206-4952-2020-41-2-154-163 (in Russian)
4. Timoshenko D.O., Kofiadi I.A., Gudima G.O., Kurbacheva O.M. Epigenetics of bronchial asthma. Immunologiya. 2021; 42 (2): 93-101. DOI: https://doi.org/10.33029/0206-4952-2021-42-2-93-101 (in Russian)
5. Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z., et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020; 145 (6): e20200702. DOI: https://doi.org/10.1542/peds.2020-0702
6. Cui X., Zhao Z., Zhang T., et al. A systematic review and metaanalysis of children with coronavirus disease 2019 (COVID-19). J. Med. Virol. 2021; 93 (2): 1057-69. DOI: https://doi.org/10.1002/jmv.26398
7. Williams P.C.M., Howard-Jones A.R., Hsu P., Palasanthiran P., Gray P.E., McMullan B.J., Britton P.N., Bartlett A.W. SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings. Pathology. 2020; 52 (7): 801-8.
8. World Health Organization (WHO) Coronavirus Disease (COVID-19) Pandemic. URL: https://covid19.who.int
9. Gudima G.O., Khaitov R.M., Kudlay D.A., Khaitov M.R. Molecular immunological aspects of diagnosis, prevention and treatment of coronavirus infection. Immunologiya. 2021; 42 (3): 198-210. DOI: https://doi.org/10.33029/0206-4952-2021-42-3-198-210 (in Russian)
10. Methodical recommendations «Features of clinical manifestations and treatment of the disease caused by a new coronavirus infection (COVID-19) in children». Version 2 (03.07.2020). URL: https:// static-0.minzdrav.gov.ru/system/attachments/attaches/000/050/914/original/03062020_%D0%B4%D0%B5%D1%82%D0%B8_COVID-19_v2.pdf (in Russian)
11. Morais-Almeida M., Pite H., Aguiar R., Ansotegui I., Bous-quet J. Asthma and the coronavirus disease 2019 pandemic: a literature review. Int. Arch. Allergy Immunol. 2020; 181 (9): 680-8. DOI: https://doi.org/10.1159/000509057
12. Parri N., Lenge M., Buonsenso D.; Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with COVID-19 in pediatric emergency departments in Italy. N. Engl. J. Med. 2020; 383 (2): 187-90. DOI: https://doi.org/10.1056/NEJMc2007617
13. Lu X., Zhang L., Du H., Zhang J., Li Y.Y., Qu J., et al.; Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 infection in children. N. Engl. J. Med. 2020; 382 (17): 1663-5.
tor ACE2. J. Allergy Clin. Immunol. 2020; 146 (1): 203-6.e3. DOI: https://doi.org/10.1016/jjaci.2020.04.009
21. Хаитов Р.М., Пинегин Б.В., Пащенков М.В. Эпителиальные клетки дыхательных путей как равноправные участники врожденного иммунитета и потенциальные мишени для иммуно-тропных средств. Иммунология. 2020; 41 (2): 107-13. DOI: https:// doi.org/10.33029/0206-4952-2020-41-2-107-113
22. Ciprandi G., Licari A., Filippelli G., Tosca M.A., Marseg-lia G.L. Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019. Ann. Allergy Asthma Immunol. 2020; 125 (3): 361-2. DOI: https://doi.org/10.1016/j. anai.2020.06.001
23. Bhatraju P.K., Ghassemieh B.J., Nichols M., Kim R., Jerome K.R., Nalla A.K. et al. COVID-19 in critically ill patients in the Seattle region: case series. N. Engl. J. Med. 2020; 382 (21): 2012-22.
24. Global strategy for asthma management and prevention (GINA). Updated 2020. URL: www.ginasthma.com
25. Yamaya M., Nishimura H., Deng X. et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir. Investig. 2020; 58: 15568. DOI: https://doi.org/https://doi.org/10.1016/j.resinv.2019.12.005
26. Peters M.C., Sajuthi S., Deford P., Christenson S., Rios C.L., Montgomery M.T. et al. COVID-19 related genes in sputum cells in asthma: relationship to demographic features and corticosteroids. Am. J. Respir. Crit. Care Med. 2020; 202: 83-90.
14. Lu X., Zhang L., Du H., Zhang J., Li Y.Y., Qu J., et a.; Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 infection in children. N. Engl. J. Med. 2020; 382(17): 1663-5.
15. Papadopoulos N.G., Custovic A., Deschildre A., et al. Impact of COVID-19 on pediatric asthma: practice adjustments and disease burden. J. Allergy Clin. Immunol. Pract. 2020; 8: 2592-9. DOI: https://doi.org/10.1016/jjaip.2020.06.001
16. Papadopoulos N.G., Mathioudakis A.G., Custovic A., et al. Childhood asthma outcomes during the COVID-19 pandemic: findings from the PeARL multinational cohort. Allergy. 2021; Feb. 20. DOI: https://doi.org/10.1111/all.14787
17. Chavasse R.J. COVID-19: reduced asthma presentations in children BMJ. 2020; 370: m2806. DOI: https://doi.org/10.1136/bmj.m2806
18. Kaye L., Theye B., Smeenk I., Gondalia R., Barrett M.A., Stempel D.A. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. J. Allergy Clin. Immunol. Pract. 2020; 8: 2385-6.
19. Krivec U., Kofol Seliger A., Tursic J. COVID-19 lockdown dropped the rate of paediatric asthma admissions. Arch. Dis. Child. 2020; 105: 809-10.
20. Jackson D.J., Busse W.W., Bacharier L.B., et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J. Allergy Clin. Immunol. 2020; 146 (1): 203-6.e3. DOI: https://doi.org/10.1016/jjaci.2020.04.009
21. Khaitov R.M., Pinegin B.V., Pashchenkov M.V. Epithelial cells of the respiratory tract as equal participants in innate immunity and potential targets for immunotropic agents. Immunologiya. 2020; 41 (2): 107-13. DOI: https://doi.org/10.33029/0206-4952-2020-41-2-107-113 (in Russian)
22. Ciprandi G., Licari A., Filippelli G., Tosca M.A., Marseg-lia G.L. Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019. Ann. Allergy Asthma Immunol. 2020; 125 (3): 361-2. DOI: https://doi.org/10.1016/j. anai.2020.06.001
23. Bhatraju P.K., Ghassemieh B.J., Nichols M., Kim R., Jerome K.R., Nalla A.K., et al. COVID-19 in critically ill patients in the Seattle region: case series. N. Engl. J. Med. 2020; 382 (21): 2012-22.
24. Global strategy for asthma management and prevention (GINA). Updated 2020. URL: www.ginasthma.com
25. Yamaya M., Nishimura H., Deng X., et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir. Investig. 2020; 58: 15568. DOI: https://doi.org/https://doi.org/10.1016/j.resinv.2019.12.005
26. Peters M.C., Sajuthi S., Deford P., Christenson S., Rios C.L., Montgomery M.T., et al. COVID-19 related genes in sputum cells in asthma: relationship to demographic features and corticosteroids. Am. J. Respir. Crit. Care Med. 2020; 202: 83-90.